Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Earned Income Tax Credit to Benefit Low-Income Taxpayers in 2023 and 2024
    Earned Income Tax Credit to Benefit Low-Income Taxpayers in 2023 and 2024 Business
  • War Day 169: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 169: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Zapp i300 electrifies Selfridges
    Zapp i300 electrifies Selfridges Business
  • The Virtual Foundry Makes Metal 3D Printing Accessible with Universal Expansion and Bambu Lab Distribution agreement
    The Virtual Foundry Makes Metal 3D Printing Accessible with Universal Expansion and Bambu Lab Distribution agreement Aviation
  • War Day 240: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin
    War Day 240: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • War Day 64 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych
    War Day 64 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych World News
  • Money Magazine Names Augusta Precious Metals ‘Best Overall’ in 2022 Best Gold IRA Company Reviews
    Money Magazine Names Augusta Precious Metals ‘Best Overall’ in 2022 Best Gold IRA Company Reviews Business
  • Technology Distributor WAV and Affiliate Companies Announce Distribution Agreement With Adtran
    Technology Distributor WAV and Affiliate Companies Announce Distribution Agreement With Adtran Business
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

Posted on December 22, 2022 By NewsEditor
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery PlatformGb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery PlatformGb Sciences' innovative approach harnesses the power of plant-based treatments as simplified mixtures that target dangerous hyperinflammatory responses to viral infections.

Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

LAS VEGAS - December 22, 2022 - (Newswire.com)

Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is developing cannabis-inspired anti-inflammatory therapeutics that address Cytokine Release Syndrome (CRS) caused by viral infections like COVID-19 and others. Over the two pandemic years, more than 540 million people across the world contracted COVID-19 and 6.3 million died from the hyperinflammatory side effects related to this viral infection, which inspired Gb Sciences to create anti-inflammatory drugs designed to treat future viral outbreaks that elicit these dangerous hyperinflammatory responses. 

The global anti-inflammatory therapeutics market size was estimated at USD 99.6 billion in 2021, according to Precedence Research, and is expected to hit USD 127.5 billion by 2030, with a registered CAGR of 4.5% from 2022 to 2030. Gb Sciences announced in May 2022 that FHI Clinical would consult and write the draft clinical trial protocol for a first-in-human trial of these proprietary cannabinoid-containing formulations. One key differentiator of Gb Sciences' CRS therapeutic is the early-intervention and preventative opportunities for patients when they first discover they have been exposed to a virus that causes hyperinflammation. This therapeutic may also be useful for patients who are experiencing CRS as a side effect of certain new cancer therapeutics, such as Bispecific T-cell engaging (BiTE) single-chain antibody constructs and chimeric antigen receptor (CAR) T-cells.

"Our research shows promise for the potential use of cannabinoids within cannabinoid-containing mixtures as a treatment option for hyperinflammation. There is still a need for effective treatments to combat the hyperinflammatory effects of certain viruses. Our cannabis-inspired therapeutics were designed to reset the immune system after hyperinflammation has been triggered, providing relief by targeting our human immune response to a virus, without being tied to a specific variant or the virus itself," said Andrea Small-Howard, President and Chief Science Officer of Gb Sciences.

Gb Sciences used PhAROS™, its proprietary AI-enabled drug discovery platform, to identify these therapeutic mixtures that were designed to reduce the levels of specific cytokines and pro-inflammatory processes triggered by viruses, while preserving the immune functions and cytokines necessary to fight viral infections. Gb Sciences recently published a white paper on their novel development program titled "Utilizing Proprietary AI/ML Technology, Novel Cannabis-Inspired Mixtures Are Developed as Innovative Anti-Inflammatory Therapeutics"; download it here. 

A proof-of-concept study completed by researchers at Michigan State University in 2021 found that Gb Sciences' proprietary cannabis-inspired minimum essential mixtures (MEM) reduced cytokine release syndrome biomarkers. Gb Sciences' MEM, containing either two or three cannabinoids each, reduced the levels of inflammatory biomarkers more than the sum of the anti-inflammatory effects of the single ingredients tested separately. The ratios of those cannabinoid molecules within the MEM formulations also greatly influenced their anti-inflammatory potential, the study reported. 

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary GbS Global Biopharma, Inc. The "plant-inspired" active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six issued U.S. and three issued foreign patents, as well as 17 U.S. and 51 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety, and depression are currently in preclinical animal studies with researchers at the National Research Council Canada. The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes," and words of similar import may identify forward-looking statements. These statements are not historical facts but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.


Contact Information:
Alexis Quintal
[email protected]


Press Release Service by Newswire.com

Original Source: Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
Business

Post navigation

Previous Post: Following More Than a Decade of Development, TM Technologies Demonstrates More Than 50% Increase in Data Efficiency for Telecom
Next Post: Announcing the launch of pixiv’s time-limited event ‘myBESTpixiv2022’, where users can look back on and share their activities over the past year

Related Posts

  • The Rosie Report Finds a Layered Workforce is a Key to Preventing Burnout and Adding Diversity in Thought and Expertise
    The Rosie Report Finds a Layered Workforce is a Key to Preventing Burnout and Adding Diversity in Thought and Expertise Business
  • Switch Introduces Handbag Rentals From /Month
    Switch Introduces Handbag Rentals From $45/Month Business
  • Tidal Wave Auto Spa Raises 0,000 on 14th Annual Charity Day
    Tidal Wave Auto Spa Raises $350,000 on 14th Annual Charity Day Business
  • BongiTech Rebrands to Expand and Enhance Web Development Services
    BongiTech Rebrands to Expand and Enhance Web Development Services Business
  • Aston University Professor Presents New Research on AI-based Software-Defined Neuromorphic Computing at IEEE CLOUD 2025
    Aston University Professor Presents New Research on AI-based Software-Defined Neuromorphic Computing at IEEE CLOUD 2025 Business
  • Rockwater Plumbing Now Certified to Provide Water Filtration and Softener Services
    Rockwater Plumbing Now Certified to Provide Water Filtration and Softener Services Business
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Financial Outsourcing Services Market to Reach $74.72 Billion by 2029 with 8.3% CAGROctober 8, 2025
  • Fairhope Aerospace Earns SBA Veteran-Owned Small Business CertificationOctober 8, 2025
  • Experience Ibogaine Contributes to Ongoing Research on Ibogaine’s Interactions with the BodyOctober 1, 2025
  • Financial Grade Security Chip Global Market Report 2025| Business Growth, Current and Future Trends till 2029October 1, 2025
  • Trade Technologies Launches Global SBLC & Guarantee Management SolutionsSeptember 30, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Staffing Industry Leader NEXTAFF Opens Kansas City, Kansas, Office
    Staffing Industry Leader NEXTAFF Opens Kansas City, Kansas, Office Business
  • War Day 230: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 230: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Ambassador Fick’s Travel to Seoul, Republic of Korea and the ASEAN Digital Ministers Meeting, in Boracay, Philippines
    Ambassador Fick’s Travel to Seoul, Republic of Korea and the ASEAN Digital Ministers Meeting, in Boracay, Philippines World News
  • Trading Mentor Online Is Now Offering One-On-One Expert Coaching For Forex Trading
    Trading Mentor Online Is Now Offering One-On-One Expert Coaching For Forex Trading World News
  • University of Arizona Global Campus assistant dean recognized with Presidential Lifetime Achievement Award
    University of Arizona Global Campus assistant dean recognized with Presidential Lifetime Achievement Award World News
  • Crimean Bridge Collapsed or Got tired? –  Volodymyr Zolkin
    Crimean Bridge Collapsed or Got tired? – Volodymyr Zolkin World News
  • Secretary Antony J. Blinken And Nigerien Foreign Minister Hassoumi Massoudou at a Joint Press Availability
    Secretary Antony J. Blinken And Nigerien Foreign Minister Hassoumi Massoudou at a Joint Press Availability World News
  • Instro AI Assistant deployed by AMADA, creating global knowledge base saving nearly 1,000 field engineer hours to date
    Instro AI Assistant deployed by AMADA, creating global knowledge base saving nearly 1,000 field engineer hours to date Aviation
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .